Vlasic Labs CBD Products Qualify for CMS Pilot Program | Cannabis Business Times
Comments Off on Vlasic Labs CBD Products Qualify for CMS Pilot Program | Cannabis Business Times
March 31, 2026
Vlasic Labs CBD products have qualified for the CMS pilot program, signaling a key regulatory milestone. This CMS pilot program inclusion may influence insurance coverage and clinical practices. Clinicians should monitor this CMS pilot program as it…
Did Carrier have to Cough up Cash for THC Edibles of Worker with Chronic Pain?
Comments Off on Did Carrier have to Cough up Cash for THC Edibles of Worker with Chronic Pain?
March 26, 2026
Workers compensation medical cannabis coverage is evolving, especially for chronic pain cases involving THC edibles. This development impacts insurance decisions and patient access. Understanding these changes helps clinicians and patients navigate…
5 Transformative Effects of Cannabis Rescheduling: Medical Insight
Comments Off on 5 Transformative Effects of Cannabis Rescheduling: Medical Insight
May 2, 2024
In a recent landmark announcement on Cannabis Rescheduling, President Biden expressed his administration's commitment to support the rescheduling of cannabis from Schedule 1 to Schedule 3 of the Controlled Substances Act. This shift could…